Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nevro Spine-Stim Patents Escape Re-Review By PTO

This article was originally published in The Gray Sheet

Executive Summary

The Patent Trial and Appeals Board won’t review a Nevro spinal cord stimulator patent after a challenge from Boston Scientific claimed the patent was invalid because it was too similar to prior knowledge in the field. The unusual decision not to even launch a so-called inter partes review in this case should be comforting to device patent holders, an attorney says.

Advertisement

Related Content

Nevro Will Take On Spinal Cord Stim Leaders As Senza Is Stamped 'Superior'

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT034424

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel